NASDAQ:MDXG

MiMedx Group News Headlines

$12.72
+0.64 (+5.30 %)
(As of 04/9/2021 12:00 AM ET)
Add
Compare
Today's Range
$11.92
Now: $12.72
$12.78
50-Day Range
$8.59
MA: $10.10
$12.18
52-Week Range
$3.30
Now: $12.72
$12.78
Volume616,436 shs
Average Volume572,593 shs
Market Capitalization$1.42 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.71

Headlines

MiMedx Group (NASDAQ MDXG) News Headlines Today

SourceHeadline
MiMedx Group (NASDAQ:MDXG) Shares Gap Down to $12.18MiMedx Group (NASDAQ:MDXG) Shares Gap Down to $12.18
americanbankingnews.com - April 7 at 11:00 AM
MiMedx Group (NASDAQ:MDXG) Trading Up 5.7%MiMedx Group (NASDAQ:MDXG) Trading Up 5.7%
americanbankingnews.com - April 6 at 2:30 PM
MiMedx Group (NASDAQ:MDXG) Sets New 12-Month High at $11.44MiMedx Group (NASDAQ:MDXG) Sets New 12-Month High at $11.44
americanbankingnews.com - April 5 at 1:28 PM
MiMedx Group, Inc. (NASDAQ:MDXG) Sees Large Decline in Short InterestMiMedx Group, Inc. (NASDAQ:MDXG) Sees Large Decline in Short Interest
americanbankingnews.com - April 1 at 5:26 AM
MiMedx Group (NASDAQ:MDXG) Shares Up 8.1%MiMedx Group (NASDAQ:MDXG) Shares Up 8.1%
americanbankingnews.com - March 30 at 2:55 PM
MiMedx Awarded Amniotic Tissue Supplier Agreement with Premier® Inc.’s SURPASS™ Purchasing ProgramMiMedx Awarded Amniotic Tissue Supplier Agreement with Premier® Inc.’s SURPASS™ Purchasing Program
finance.yahoo.com - March 30 at 8:46 AM
MiMedx Group (NASDAQ:MDXG) Shares Gap Down to $9.80MiMedx Group (NASDAQ:MDXG) Shares Gap Down to $9.80
americanbankingnews.com - March 29 at 11:48 AM
MiMedx Group (NASDAQ:MDXG) Trading Down 6%MiMedx Group (NASDAQ:MDXG) Trading Down 6%
americanbankingnews.com - March 25 at 11:37 AM
MiMedx Group (NASDAQ:MDXG) Coverage Initiated by Analysts at HC WainwrightMiMedx Group (NASDAQ:MDXG) Coverage Initiated by Analysts at HC Wainwright
americanbankingnews.com - March 25 at 9:00 AM
Contrasting MiMedx Group (NASDAQ:MDXG) and Haemonetics (NYSE:HAE)Contrasting MiMedx Group (NASDAQ:MDXG) and Haemonetics (NYSE:HAE)
americanbankingnews.com - March 23 at 10:44 PM
MiMedx Group (NASDAQ:MDXG) Stock Price Up 5.1%MiMedx Group (NASDAQ:MDXG) Stock Price Up 5.1%
americanbankingnews.com - March 22 at 11:47 AM
MiMedx Group (NASDAQ:MDXG) Shares Gap Up to $8.81MiMedx Group (NASDAQ:MDXG) Shares Gap Up to $8.81
americanbankingnews.com - March 19 at 3:48 PM
HC Wainwright Begins Coverage on MiMedx Group (NASDAQ:MDXG)HC Wainwright Begins Coverage on MiMedx Group (NASDAQ:MDXG)
americanbankingnews.com - March 19 at 8:18 AM
MiMedx Group, Inc. (MDXG) CEO Tim Wright on Q4 2020 Results - Earnings Call TranscriptMiMedx Group, Inc. (MDXG) CEO Tim Wright on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - March 11 at 4:47 AM
MiMedx Group EPS misses by $0.12, beats on revenueMiMedx Group EPS misses by $0.12, beats on revenue
seekingalpha.com - March 10 at 3:02 PM
MiMedx Group, Inc. to Host Earnings CallMiMedx Group, Inc. to Host Earnings Call
finance.yahoo.com - March 9 at 8:41 AM
MiMedx: Q4 Earnings SnapshotMiMedx: Q4 Earnings Snapshot
finance.yahoo.com - March 8 at 7:17 PM
MiMedx to Participate at Upcoming Investor ConferencesMiMedx to Participate at Upcoming Investor Conferences
finance.yahoo.com - March 3 at 12:24 PM
MiMedx to Host Fourth Quarter and Full Year 2020 Operating and Financial Results Conference Call on March 9MiMedx to Host Fourth Quarter and Full Year 2020 Operating and Financial Results Conference Call on March 9
finance.yahoo.com - March 2 at 9:07 AM
Should MiMedx Group (NASDAQ:MDXG) Be Disappointed With Their 41% Profit?Should MiMedx Group (NASDAQ:MDXG) Be Disappointed With Their 41% Profit?
finance.yahoo.com - February 25 at 11:14 AM
CEO Who Blamed His Cancer on Short Sellers Set for SentencingCEO Who Blamed His Cancer on Short Sellers Set for Sentencing
finance.yahoo.com - February 23 at 12:56 PM
MDXG: From Womb to WoundMDXG: From Womb to Wound
finance.yahoo.com - February 18 at 2:45 PM
Reminder: MiMedx to Present at the 39th Annual J.P. Morgan Healthcare ConferenceReminder: MiMedx to Present at the 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 6 at 8:12 AM
MiMedx to Participate at the H.C. Wainwright BioConnect 2021 ConferenceMiMedx to Participate at the H.C. Wainwright BioConnect 2021 Conference
finance.yahoo.com - January 4 at 8:11 AM
MiMedx: This Is What Institutional Investment Looks LikeMiMedx: This Is What Institutional Investment Looks Like
seekingalpha.com - December 24 at 12:32 PM
MiMedx to Present at the 39th Annual J.P. Morgan Healthcare ConferenceMiMedx to Present at the 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - December 7 at 9:00 AM
MiMedx Appoints Jack Howarth as Senior Vice President, Investor RelationsMiMedx Appoints Jack Howarth as Senior Vice President, Investor Relations
benzinga.com - December 1 at 9:35 AM
MiMedx To Present at the Piper Sandler 32nd Annual Virtual Healthcare ConferenceMiMedx To Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
finance.yahoo.com - November 24 at 6:38 PM
News for MiMedx Group IncNews for MiMedx Group Inc
markets.businessinsider.com - November 20 at 11:07 PM
MiMedx: Amniotic Hypotheses Create Decent Fundamental MomentumMiMedx: Amniotic Hypotheses Create Decent Fundamental Momentum
seekingalpha.com - November 19 at 2:53 PM
MiMedx To Host Virtual 2020 Annual Meeting of Shareholders on Friday, November 20MiMedx To Host Virtual 2020 Annual Meeting of Shareholders on Friday, November 20
finance.yahoo.com - November 13 at 10:23 AM
MiMedx Announces Third Quarter 2020 Financial ResultsMiMedx Announces Third Quarter 2020 Financial Results
finance.yahoo.com - November 4 at 5:47 PM
MiMedx To Advance the Conversation of Study Bias in the Clinical Evaluation of Skin Substitutes in Chronic Wounds at SAWC FALLMiMedx To Advance the Conversation of Study Bias in the Clinical Evaluation of Skin Substitutes in Chronic Wounds at SAWC FALL
finance.yahoo.com - November 4 at 12:46 PM
MiMedx Shares to Commence Trading on Nasdaq on Wednesday, November 4, 2020MiMedx Shares to Commence Trading on Nasdaq on Wednesday, November 4, 2020
finance.yahoo.com - November 3 at 8:04 PM
Largest U.S. payor to cover MiMedxs EpiFix for diabetic foot ulcersLargest U.S. payor to cover MiMedx's EpiFix for diabetic foot ulcers
seekingalpha.com - November 3 at 10:04 AM
MiMedx Announces Largest U.S. Commercial Payor Will Provide Coverage for EpiFix in the Treatment of Diabetic Foot UlcersMiMedx Announces Largest U.S. Commercial Payor Will Provide Coverage for EpiFix in the Treatment of Diabetic Foot Ulcers
finance.yahoo.com - November 3 at 10:04 AM
MiMedx Announces Relisting on NasdaqMiMedx Announces Relisting on Nasdaq
finance.yahoo.com - October 30 at 7:17 PM
MiMedx to Host Third Quarter 2020 Financial Results Call on November 5MiMedx to Host Third Quarter 2020 Financial Results Call on November 5
finance.yahoo.com - October 29 at 6:53 PM
Soft Tissue Allografts Market Huge Growth Opportunities and Trends to 2026Soft Tissue Allografts Market Huge Growth Opportunities and Trends to 2026
marketwatch.com - September 27 at 6:00 PM
MiMedx sees Q3 sales as high as $64MMiMedx sees Q3 sales as high as $64M
seekingalpha.com - September 21 at 9:18 AM
MiMedx Concludes Enrollment for Phase 2B Study of Osteoarthritis (OA) of the KneeMiMedx Concludes Enrollment for Phase 2B Study of Osteoarthritis (OA) of the Knee
finance.yahoo.com - September 21 at 9:18 AM
MiMedx Concludes Enrollment for Phase 3 Plantar Fasciitis TrialMiMedx Concludes Enrollment for Phase 3 Plantar Fasciitis Trial
finance.yahoo.com - September 17 at 12:27 PM
MiMedx Launches EpiCord Expandable Placental Allograft as Addition to Market Leading PortfolioMiMedx Launches EpiCord Expandable Placental Allograft as Addition to Market Leading Portfolio
finance.yahoo.com - September 14 at 8:58 AM
MiMedx to Discuss Strategic Priorities at Upcoming Virtual 2019 Annual Meeting of ShareholdersMiMedx to Discuss Strategic Priorities at Upcoming Virtual 2019 Annual Meeting of Shareholders
marketwatch.com - August 24 at 9:18 AM
MiMedx Group, Inc. (MDXG) CEO Tim Wright on Q2 2020 Results - Earnings Call TranscriptMiMedx Group, Inc. (MDXG) CEO Tim Wright on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 11 at 4:35 PM
MiMedx Welcomes Robert B. Stein, M.D., Ph.D., to Head Revitalized R&D EffortsMiMedx Welcomes Robert B. Stein, M.D., Ph.D., to Head Revitalized R&D Efforts
finance.yahoo.com - August 10 at 9:59 AM
MiMedx Files Second Quarter 2020 Form 10-QMiMedx Files Second Quarter 2020 Form 10-Q
finance.yahoo.com - August 4 at 5:52 PM
MiMedx Files Definitive Proxy MaterialsMiMedx Files Definitive Proxy Materials
finance.yahoo.com - August 3 at 10:11 AM
MiMedx Adds Rohit Kashyap, Ph.D., to Leadership Team as Executive Vice President and Chief Commercial OfficerMiMedx Adds Rohit Kashyap, Ph.D., to Leadership Team as Executive Vice President and Chief Commercial Officer
finance.yahoo.com - July 28 at 8:14 AM
MiMedx Fixes Cash Concerns With Relisting Right Around The CornerMiMedx Fixes Cash Concerns With Relisting Right Around The Corner
seekingalpha.com - July 15 at 9:20 AM
This page was last updated on 4/10/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.